PDF icon Download PDF
Open Access
CC BY-NC-ND 4.0 · J Lab Physicians 2023; 15(04): 498-502
DOI: 10.1055/s-0043-1768167
Original Article

Effect of Statins on the Inflammatory Markers in Patients with Coronary Artery Disease

Sujatha Mahadevarao Premnath
1   Department of Biochemistry, Pondicherry Institute of Medical Science, Pondicherry, India
,
Sunil Kumar Nanda
1   Department of Biochemistry, Pondicherry Institute of Medical Science, Pondicherry, India
,
Lopamudra Ray
2   Department of Biochemistry, CCM Government Medical College, Durg, Chhattisgarh, India
,
Mark Chirstopher Arokiaraj
3   Department of Cardiology, Pondicherry Institute of Medical Science, Pondicherry, India
› Author Affiliations
› Further Information
Also available ateRef
  Permissions and Reprints
Preview

Abstract

Introduction Atherosclerosis mediated by inflammatory markers is the corner stone in the pathology of coronary artery disease (CAD). Hyperlipidemia, one of the risk factors is treated with statins. Statins also have a pleotropic role in reducing inflammation. Effect of statins on two inflammatory markers pentraxin 3(PTX 3) and high sensitivity C-reactive protein (hs-CRP) is explored in this study.

Objective This article estimates the levels of serum PTX 3 and hs-CRP in CAD patients with and without statin therapy and correlates the levels with low-density lipoprotein cholesterol (LDL-c) and high-density lipoprotein cholesterol (HDL-c) in CAD patients without statin therapy.

Material and Methods This was a cross-sectional study conducted on 62 patients with CAD diagnosed by coronary angiogram. They were divided into two groups. Group I were the CAD patients on statin therapy and group II were CAD patients who never had any lipid lowering drugs irrespective of their lipid values. Serum PTX3, hs-CRP, and lipid profile were estimated in these groups. Comparison between the groups was done using Student's t-test and correlation analyzed using Pearson's correlation.

Results Serum PTX 3 and hs-CRP levels were higher than the reference range in both the groups. But group I showed significantly low PTX 3 levels (p-value = 0.032) compared with group II. There was a significant positive relationship between PTX 3 and LDL-c (p = 0.003) in group II.

Conclusion CAD patients on statin therapy have lower vessel wall inflammation compared with patients without statin therapy.

Keywords

C-reactive protein - coronary artery disease - pentraxin 3 - statins


Publication History

Received: 01 December 2022

Accepted: 06 February 2023

Article published online:
18 April 2023

© 2023. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India